Federal Register / Vol. 69, No. 192 / Tuesday, October 5, 2004 / Notices 59615

FOR FURTHER INFORMATION CONTACT:

Janet Neal, Wild Horse and Burro Public 

Outreach Specialist, 775–861–6583. 

Individuals who use a 

telecommunications device for the deaf 

(TDD) may reach Ms. Neal at any time 

by calling the Federal Information Relay 

Service at 1–800–877–8339.

SUPPLEMENTARY INFORMATION: 

I. Public Meeting 

Under the authority of 43 CFR part 

1784, the Wild Horse and Burro 

Advisory Board advises the Secretary of 

the Interior, the Director of the BLM, the 

Secretary of Agriculture, and the Chief 

of Forest Service, on matters pertaining 

to management and protection of wild, 

free-roaming horses and burros on the 

Nation’s public lands. The tentative 

agenda for the meeting is: 

Monday, November 8, 2004 (8 a.m.–5 

p.m.) 

8 a.m. Call to Order & Introductions: 

8:15 a.m. Old Business: 

Approval of August 2004 Minutes 

2005 Nominations Update 

FY 04–FY 05 Updates 

8:45 a.m. Program Updates: 

Gathers 

Adoptions 

Facilities 

New Long Term Holding Contracts 

Break (9:30 a.m.–9:45 a.m.) 

9:45 a.m.–Program Updates (continued): 

National Adoption Plan 

Forest Service Update 

Fertility Control 

Lunch (11:30 p.m.–1 p.m.) 

1 p.m.–New Business: 

Response to Advisory Board 

Recommendation 

Break (2:30 p.m.–2:45 p.m.) 

2:45 p.m. Board Recommendations 

4 p.m. Public Comments 

4:45 p.m. Recap/Summary/Next 

Meeting/Date/Site 

5–6 p.m. Adjourn: Roundtable 

Discussion to Follow 

The meeting site is accessible to 

individuals with disabilities. An 

individual with a disability needing an 

auxiliary aid or service to participate in 

the meeting, such as interpreting 

service, assistive listening device, or 

materials in an alternate format, must 

notify the person listed under FOR

FURTHER INFORMATION CONTACT two 

weeks before the scheduled meeting 

date. Although the BLM will attempt to 

meet a request received after that date, 

the requested auxiliary aid or service 

may not be available because of 

insufficient time to arrange it. 

The Federal Advisory Committee 

Management Regulations (41 CFR 101–

6.1015(b)), require BLM to publish in 

the Federal Register notice of a meeting 

15 days prior to the meeting date. 

II. Public Comment Procedures 

Members of the public may make oral 

statements to the Advisory Board on 

November 8, 2004, at the appropriate 

point in the agenda. This opportunity is 

anticipated to occur at 4 p.m., local 

time. Persons wishing to make 

statements should register with the BLM 

by noon on November 8, 2004, at the 

meeting location. Depending on the 

number of speakers, the Advisory Board 

may limit the length of presentations. At 

previous meetings, presentations have 

been limited to three minutes in length. 

Speakers should address the specific 

wild horse and burro-related topics 

listed on the agenda. Speakers must 

submit a written copy of their statement 

to the address listed in the ADDRESSES

section or bring a written copy to the 

meeting. 

Participation in the Advisory Board 

meeting is not a prerequisite for 

submission of written comments. The 

BLM invites written comments from all 

interested parties. Your written 

comments should be specific and 

explain the reason for any 

recommendation. The BLM appreciates 

any and all comments, but those most 

useful and likely to influence decisions 

on management and protection of wild 

horses and burros are those that are 

either supported by quantitative 

information or studies or those that 

include citations to and analysis of 

applicable laws and regulations. Except 

for comments provided in electronic 

format, speakers should submit two 

copies of their written comments where 

feasible. The BLM will not necessarily 

consider comments received after the 

time indicated under the DATES section 

or at locations other than that listed in 

the ADDRESSES section. 

In the event there is a request under 

the Freedom of Information Act (FOIA) 

for a copy of your comments, the BLM 

will make them available in their 

entirety, including your name and 

address. However, if you do not want 

the BLM to release your name and 

address in response to a FOIA request, 

you must state this prominently at the 

beginning of your comment. The BLM 

will honor your request to the extent 

allowed by law. The BLM will release 

all submissions from organizations or 

businesses, and from individuals 

identifying themselves as 

representatives or officials of 

organizations or businesses, in their 

entirety, including names and 

addresses. 

Electronic Access and Filing Address 

Speakers may transmit comments 

electronically via the Internet to: 

Janet_Neal@blm.gov. Please include the 

identifier ‘‘WH&B’’ in the subject of 

your message and your name and 

address in the body of your message.

Dated: September 30, 2004. 

Thomas H. Dyer, 

Assistant Director, Renewable Resources and 

Planning.

[FR Doc. 04–22388 Filed 10–4–04; 8:45 am] 

BILLING CODE 4310–84–P

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Accreditation Association 

for Ambulatory Health Care, Inc. 

Notice is hereby given that, on August 

26, 2004, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Accreditation 

Association for Ambulatory Health Care, 

Inc. (AAAHC) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is Accreditation Association for 

Ambulatory Health Care, Inc., 

(‘‘AAAHC’’) Wilmette, IL 60091. The 

nature and scope of AAAHC’s standard 

development activities are: AAAHC 

develops and maintains standards of 

encourage the voluntary attainment of 

high-quality care in organizations 

providing health care services in 

ambulatory settings. The standards 

describe characteristics that AAAHC 

determines as indicative of an 

accreditable organization. The 

accreditation process involves selfassessment by a health care 

organizations, as well as a thorough 

review by AAAHC’s expert surveyors to 

determine compliance with AAAHC 

standards. AAAHC updates its 

standards on a year basis, with input 

from many health care organizations 

and the public. The standards and 

survey procedures are contained in the 

59616 Federal Register / Vol. 69, No. 192 / Tuesday, October 5, 2004 / Notices 

AAAHC Accreditation Handbook for 

Ambulatory Health Care.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 04–22296 Filed 10–4–04; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Accredited Standards 

Committee X9, Inc. 

Notice is hereby given that, on August 

23, 2004, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), the Accredited 

Standards Committee X9, Inc. (‘‘ASC 

X9’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to Section 6(b) of the Act, 

the name and principal place of 

business of the standards development 

organization is: Accredited Standards 

Committee X9, Inc. (‘‘ASC X9’’), 

Annapolis, MD. The nature and scope of 

ASC X9’s standards development 

activities are to develop and promote 

standards for the financial services 

industry in order to facilitate services 

and products. ASC X9’s objectives are to 

support (maintain, enhance and 

promote use of) existing standards; 

facilitate development of new, open 

standards based upon consensus; 

incorporate nonproprietary items 

developed by other organizations where 

appropriate; provide a common source 

for all standards affecting the financial 

services industry; focus on concurrent 

and future standards needs of the 

financial services industry standards; 

and participate in and promote the 

development of international standards. 

Additional information concerning 

ASC X9 may be obtained from Cynthia 

L. Fuller, Executive Director, Accredited 

Standards Committee X9, Inc., P.O. box 

4035, Annapolis, MD 21403, Tel. (410) 

267–7707.

Dorothy B. Fountain, 

Deputy Director of Operations Antitrust 

Division.

[FR Doc. 04–22294 Filed 10–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—American Optometric 

Association Commission on 

Ophthalmic Standards 

Notice is hereby given that, on August 

5, 2004, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), American 

Optometric Association Commission on 

Ophthalmic Standards (‘‘AOA CmOS’’) 

has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) The name 

and principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to Section 6(a) of the Act, 

the name and principal place of 

business of the standards development 

organization is: American Optometric 

Association Commission on Ophthalmic 

Standards, St. Louis, MO. The nature 

and scope of AOA CmOS’s standards 

development activities are: The AOA 

CmOS provides for voluntary, impartial 

ophthalmic product evaluation resulting 

in the issuance of a seal of acceptance 

for those ophthalmic products that meet 

published standards specifications 

developed by the AOA CmOS, 

including biological, laboratory, and/or 

clinical evolutions, or the issuance of a 

seal of certification for those ophthalmic 

products that meet standards already 

approved by accepted standards 

organizations and which are designated 

for use by the AOA CmOS. The AOA 

CmOS selects the categories of products 

to be evaluated and develops evaluation 

specifications/standards for those 

ophthalmic products using the 

American National Standard Institute’s 

Third Party Certification Program 

principles (ANSI Z34. 1–1993). Product 

categories for which the AOA CmOS 

currently has approved standards are: 

(1) Glare reduction filters for video 

display terminals: (2) non-prescription 

sunglasses; (3) privacy filters for video 

display terminals; (4) anti-reflection 

interference coatings for video display 

terminals; (5) storage cases used by 

wearers of contact lenses; (6) suction 

cup devices used to remove rigid 

contact lenses from the human eye; and 

(7) ultraviolet absorbers and blockers. 

Additional categories are always under 

review. The AOA CmOS is a ninemember commission that abides by a 

strict Code of Conduct for reviewing any 

applications for seals of acceptance of 

certification and for developing 

approved evaluation specifications/

standards.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 04–22295 Filed 10–4–04; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Waste Equipment 

Technology Association 

Notice is hereby given that on August 

17, 2004, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 

§ 4301 et seq. (‘‘the Act’’), the Waste 

Equipment Technology Association 

(WASTEC) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing: (1) The name 

and principal place of business of the 

standards development organization; 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to Section 6(b) of the Act, 

the name and principal place of 

business of the standards development 

organization is: Waste Equipment 

Technology Association, Washington, 

DC. The nature and scope of WASTEC’s 

standards development activities are 

that WASTEC serves as the Secretariat 

for the American National Standards 

Institute (ANSI) Accredited Standards 

Committee Z245 on Equipment 

Technology and Operations for Wastes 

and Recyclable Materials. WASTEC 

facilitates the development of ANSI 

safety standards for solid waste 

equipment manufacturers and users.